Everything You Need to Know About Hybrid Batteries

Rollx Vans is excited to offer the new Toyota Sienna among our selection of wheelchair-accessible minivans. The new Sienna comes standard with a powerful, responsive, and efficient hybrid engine, and it’s the first hybrid van we’ve converted for drivers and passengers with mobility needs. We’ve applied our gold standard of excellence to ensure that the Read more…

FDA Approves New Treatment for Rett Syndrome

In March, the Food and Drug Administration announced an important milestone in the fight against Rett syndrome. The FDA approved Daybue (trofinetide), a prescription oral treatment for adults and children 2 years of age and older who suffer from this rare but devastating neurological disorder. The development and approval of the first official treatment for Read more…

How Virtual Reality Benefits People with Disabilities

Virtual reality has taken incredible leaps forward in recent years, and its potential in terms of entertainment and education is nearly limitless. This technology allows us to learn, experience, and grow in ways that may have once seemed unfathomable. VR is a particularly useful tool for people with disabilities, opening the doors to new worlds, Read more…

What is the ISO 9001 Quality Standard?

Why Is ISO 9001 The World Leader In Quality Standards? Rollx Vans has maintained its standing as a safe, convenient, and trusted brand for mobility vehicles for more than four decades. There’s a lot that goes into making sure that everything we do meets and exceeds the needs of our customers. One of the core Read more…

Vehicle Hand Controls for Disabled Drivers: Gaining Mobility

When a person with disabilities decides it’s time to hit the road, there are no physical limitations to his or her journey. Relatively inexpensive hand controls for disabled drivers have made it easier than ever to get behind the wheel. For people with physical disabilities, the top concern before getting behind the wheel is how Read more…

New Muscular Dystrophy Drug Gains FDA Approval

Just this week, the U.S. Food and Drug Administration (FDA) announced their approval of a new pharmaceutical drug that could significantly change the lives of those affected by Duchenne muscular dystrophy (DMD). The new drug, named deflazacort, is a steroid-based medication that has been shown to improve muscle function in people with DMD. With consistent Read more…